Texas Sen. John Cornyn sounded the alarm that a biotech startup firm that has raised some $30 million to study diseases in embryos is working on gene-editing techniques for humans at their ...

Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its ...

The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the ...

Watson season 2 episode 10 airs December 15, 2025, on CBS. Find release time, streaming details on Paramount+, and what to ...

Because it requires so little to produce, the new strain could help bring more flavorful, environmentally friendly meat ...

In a new study, scientists at the Max Planck Institute for Evolutionary Anthropology in Leipzig analyzed the impact of more ...

Gene editing can repair mutations that prematurely halt protein synthesis, resulting in incomplete peptides that cause ...

Newly updated research shows incredible promise, but it's still just the beginning of the era of real cancer therapies.

All starting from the same DNA, neurons ultimately take on individual characteristics in the brain and body. Differences in ...

We're living in a moment where science fiction is becoming medical reality. Imagine a world where doctors can simply rewrite ...

While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have ...

Every movement you make and every memory you form depends on precise communication between neurons. When that communication is disrupted, the brain must rapidly rebalance its internal signaling to ...